New date Dutch Life Sciences conference!
April 19, 2022
Finally we are able to inform you about the definite date for the postponed 2021 edition of the Dutch Life Sciences conference. Please mark May 24, 2022 in your agenda!
April 19, 2022
Finally we are able to inform you about the definite date for the postponed 2021 edition of the Dutch Life Sciences conference. Please mark May 24, 2022 in your agenda!
April 18, 2022
In this Expert Class financing options and successful strategies for young Life Sciences & Medtech companies are being discussed. The focus is on financing options for biotech and MedTech companies till series A financing round.
February 16, 2022
A solid business development strategy is crucial for the development of life sciences products and companies. For young companies it provides funding for research and product development whereas for larger companies it manage their (IP) portfolios, adjusting risks, revenue streams and company strategy.
January 27, 2022
We all looked very much forward to organise the 2021 edition of the Dutch Life Sciences conference early 2022.
Unfortunately due to the latest announced measures by the Dutch Government to prevent the spread of COVID-19 -1,5 meters distance, ⅓ use of the venue capacity and fixed seats-, it is not possible for our production to organise our event.
January 16, 2022
Corporate governance structure for start-ups should identify roles, authority, and timing in key business decisions between shareholders, directors, and the CEO. But if there is a lack of governance structure across the business it could have a negative impact on the success of the company. For instance it could be much harder to attract funding from investors.
November 14, 2021
We all looked very much forward to the upcoming Dutch Life Sciences conference on November 25th.
Unfortunately we have to inform you that due to the Dutch Government rules to prevent the spread of COVID-19, it is currently not possible to continue our event on the scheduled date.
October 15, 2021
Changes to the healthcare systems over the last few years have made market access, pricing and reimbursement critical in driving prescriptions and ultimately sales revenue. In addition to structural changes in the healthcare systems, the dynamics of patients, healthcare policy makers and payer behaviour have altered significantly. The environment is becoming more complex, with a significant shift in the relative importance and roles of key stakeholder groups.
September 28, 2021
In 2021, two editions of the Venture Challenge took place: in the summer and in the fall. Ten innovative Life Sciences & Health startups participated in the programme. The teams worked on shaping their value propositions, vision and competitive differentiation to translate their idea into a solid business case. The winner of both editions will be announced during the Dutch Life Science Conference.